22nd Century Group executive reports RSUs and options grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
22nd Century Group (XXII) executive Robert P. Manfredonia reported equity awards dated 11/10/2025.
He received 32,429 shares of common stock at $0 pursuant to restricted stock units that vest 1/3 on November 10, 2026, 2027, and 2028. He was also granted 97,288 stock options with a $1.27 exercise price, vesting 1/3 annually per grant terms. Following these transactions, he directly owned 33,062 shares and held 1,900 options with a $46.23 exercise price expiring 03/10/2035. Share counts reflect a 1-for-23 split effected June 20, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
MANFREDONIA ROBERT P
Role
EVP of Sales and Marketing
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 97,288 | $0.00 | -- |
| Grant/Award | Common Stock | 32,429 | $0.00 | -- |
| holding | Stock option (right to buy) | -- | -- | -- |
Holdings After Transaction:
Stock option (right to buy) — 97,288 shares (Direct);
Common Stock — 33,062 shares (Direct)
Footnotes (1)
- The restricted stock units vest 1/3 per year on November 10, 2026, 2027 and 2028, subject to continued service with the Company. The amount shown reflects the number of shares held following the reported transaction, as adjusted for a 1-for-23 stock split effectuated by the issuer on June 20, 2025. Options vest 1/3 per year on the anniversary of the date of grant, subject to continued service with the Company.
FAQ
What insider transaction did XXII report on this Form 4?
An executive reported equity awards on 11/10/2025, including 32,429 common shares from RSUs and 97,288 stock options at $1.27.
How do the RSUs granted to XXII’s EVP vest?
The 32,429 RSUs vest 1/3 each on Nov 10, 2026, Nov 10, 2027, and Nov 10, 2028, subject to continued service.
What stock options were granted and at what price for XXII?
The executive received 97,288 options with an exercise price of $1.27, vesting 1/3 annually per the grant terms.
What existing options remain outstanding for the XXII executive?
He held 1,900 options with a $46.23 exercise price expiring on 03/10/2035.
Were the reported amounts adjusted for a stock split at XXII?
Yes. Amounts reflect the issuer’s 1-for-23 stock split effected on June 20, 2025.